Germany · 
Who invested in Antisense Pharma?
Antisense Pharma's investors include MIG Capital, Global Asset Fund and MIG Fonds.
20112012
$18MSeries E$11MVenture$11MSeries FGermany · Series F startup
Who invested in Antisense Pharma
3 rounds we have observed, with the 3 investors named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.
Follow Antisense Pharma and see its new rounds in your feed.Start following
Funding summaryUpdated 27 Oct 2026
$40Mraised across 3 rounds since 2010, from 3 sources
$18MSeries E$11MVenture$11MSeries F
- Latest round
- Series F, $11MJan 2012
- Biggest round
- $18MSeries E · Apr 2010
- Investors
- 3
The funding story
Each circle is a round, placed by date and sized by amount. The line above is the running total.
- First round
- Series E, $18M Apr 2010
- Biggest round
- $18M Series E · Apr 2010
- Usual gap between rounds
- 15 months the median of 2
The rounds
- Jan 2012
- Jul 2011
- Apr 2010
Who was in which round
The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.
Everyone who backed them
Missing a round, or an investor who was in one? Tell us.
Quick answers about Antisense Pharma
How much has Antisense Pharma raised?
Antisense Pharma has raised $40M across 3 rounds since 2010.
When did Antisense Pharma last raise?
Antisense Pharma's most recent round was a Series F of $11M in Jan 2012.
What was Antisense Pharma's biggest round?
Antisense Pharma's largest round on record is $18M (Series E), in Apr 2010.
Who backed Antisense Pharma first?
Antisense Pharma's first round on record, in Apr 2010, was backed by MIG Capital and Global Asset Fund.
What stage is Antisense Pharma at?
Antisense Pharma's latest named round is a Series F, in Jan 2012.
Where is Antisense Pharma based?
Antisense Pharma is based in Germany.
Companies like Antisense Pharma
In the same sector, and raised in the last eighteen months.
Find investors like these
Search every investor by what they have actually funded, then narrow to your stage and market. Free.